203 related articles for article (PubMed ID: 30822182)
61. Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.
Simon JA; Catherino W; Segars JH; Blakesley RE; Chan A; Sniukiene V; Al-Hendy A
Obstet Gynecol; 2018 Mar; 131(3):431-439. PubMed ID: 29420395
[TBL] [Abstract][Full Text] [Related]
62. An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Ali M; Chen HY; Chiang YF; Badary OA; Hsia SM; Al-Hendy A
Expert Opin Pharmacother; 2022 Mar; 23(4):421-429. PubMed ID: 35068291
[TBL] [Abstract][Full Text] [Related]
63. Current management of myomas: the place of medical therapy with the advent of selective progesterone receptor modulators.
Donnez J; Arriagada P; Donnez O; Dolmans MM
Curr Opin Obstet Gynecol; 2015 Dec; 27(6):422-31. PubMed ID: 26536207
[TBL] [Abstract][Full Text] [Related]
64. Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
Ekanem E; Talaulikar V
Adv Ther; 2021 Jan; 38(1):137-148. PubMed ID: 33201387
[TBL] [Abstract][Full Text] [Related]
65. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
66. Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial.
Brown E; Kroll R; Li H; Ng J; Pinsky B; Rodriguez JW; Thomas J; Snabes MC
Obstet Gynecol; 2023 Nov; 142(5):1068-1076. PubMed ID: 37769311
[TBL] [Abstract][Full Text] [Related]
67. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
[TBL] [Abstract][Full Text] [Related]
68. Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.
Frijlingh M; De Milliano I; Hehenkamp WJK; Huirne JAF
Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():186-192. PubMed ID: 31679806
[TBL] [Abstract][Full Text] [Related]
69. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
70. Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy.
Brun JL; Rajaonarison J; Froeliger A; Monseau-Thiburce AC; Randriamboavonjy R; Vogler A
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():13-18. PubMed ID: 29328939
[TBL] [Abstract][Full Text] [Related]
71. Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate.
Rabe T; Saenger N; Ebert AD; Roemer T; Tinneberg HR; De Wilde RL; Wallwiener M
Biomed Res Int; 2018; 2018():1374821. PubMed ID: 30539001
[TBL] [Abstract][Full Text] [Related]
72. Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment.
Courtoy GE; Henriet P; Marbaix E; de Codt M; Luyckx M; Donnez J; Dolmans MM
J Clin Endocrinol Metab; 2018 Apr; 103(4):1566-1573. PubMed ID: 29408988
[TBL] [Abstract][Full Text] [Related]
73. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
Ferrero S; Alessandri F; Vellone VG; Venturini PL; Leone Roberti Maggiore U
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():43-7. PubMed ID: 27566221
[TBL] [Abstract][Full Text] [Related]
74. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
75. Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?
Odejinmi F; Oliver R; Mallick R
Womens Health (Lond); 2017 Dec; 13(3):98-105. PubMed ID: 29105584
[TBL] [Abstract][Full Text] [Related]
76. Does Ulipristal Acetate Affect Surgical Experience at Laparoscopic Myomectomy?
Luketic L; Shirreff L; Kives S; Liu G; El Sugy R; Leyland N; Solnik MJ; Murji A
J Minim Invasive Gynecol; 2017; 24(5):797-802. PubMed ID: 28351762
[TBL] [Abstract][Full Text] [Related]
77. Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up.
Nicolás I; Martínez-Zamora MÁ; Gracia M; Carrion A; Feixas G; Bernal L; Quintas L; Rius M; Castelo-Branco C; Carmona F
Gynecol Endocrinol; 2021 Sep; 37(9):831-835. PubMed ID: 34044726
[TBL] [Abstract][Full Text] [Related]
78. Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study.
Bradley LD; Singh SS; Simon J; Gemzell-Danielsson K; Petersdorf K; Groettrup-Wolfers E; Ren X; Zvolanek M; Seitz C
Fertil Steril; 2019 Feb; 111(2):240-248. PubMed ID: 30527839
[TBL] [Abstract][Full Text] [Related]
79. Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study.
De Franciscis P; Schiattarella A; Riemma G; Labriola D; Ambrosio D; Vitale SG; Cianci A; Cucinella G; Calagna G; Colacurci N
Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):435-440. PubMed ID: 33043778
[TBL] [Abstract][Full Text] [Related]
80. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
